| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
484,223
|
471,517
|
541,940
|
592,640
| | Cost of Revenue | 232,184 | 227,629 | 268,349 | 285,632 | | |
Gross Profit
|
252,039
|
243,888
|
273,591
|
307,008
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 144,733 |
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
107,306
|
113,881
|
140,683
|
169,774
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2,571 | (53) | 477 | (33) |
|
Earnings Before Interest And Taxes | 105,404 | 111,572 | 141,237 | 169,714 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 105,404 | 111,572 | 141,237 | 169,714 |
|
Income Tax Expense | 41,908 | 43,589 | 55,095 | 59,918 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 63,496 | 67,983 | 86,142 | 109,796 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
63,496
|
67,983
|
86,142
|
109,796
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
63,496
|
67,983
|
86,142
|
109,796
|
|
1.64(2.91%) 11:03AM EDT - Nasdaq Real Time Price